Somnigroup International posted record third-quarter adjusted EPS of $1.04, up 9.5% from a year ago, on revenue of $2.351 billion, up 10.8%. Both figures still fell short of expectations. Earnings missed the $1.06 consensus by 1.9%, and revenue missed the $2.42 billion estimate by 2.9%. The bigger problem is underneath the record. The growth came almost entirely from roughly five weeks of Leggett & Platt ownership, while the legacy business shrank. Management also lowered full-year guidance for the third consecutive quarter. That is the central tension: acquisitions are inflating the headline numbers just as the core bedding franchise is losing ground.

The quality of the quarter deserves scrutiny. Leggett & Platt contributed $372.6 million of sales for the stub period after the deal closed on August 26. Without that contribution, net sales would have declined from $2.12 billion to under $1.98 billion. All three legacy segments shrank:

• Mattress Firm sales fell 5.8%.
• Tempur Sealy North America sales fell 5.8%, with wholesale down 7.2%.
• International sales fell 12.3%.

On a GAAP basis, EPS fell 10.8% to $0.74, weighed down by $35.5 million of transaction costs and a $13 million debt-extinguishment loss. Consolidated adjusted gross margin slipped to 43.0% from 45.6%, partly because Leggett carries much lower margins.

North America looked like a bright spot, with adjusted gross margin up 690 basis points to 65.5%. That improvement leaned on about $20 million of tariff refunds and $25 million of Mattress Firm synergies. The refunds will not recur, so that margin level should not be treated as a new baseline.

The call showed how quickly the operating picture has deteriorated:

• **Dreams:** On the Q2 call, management described the UK retailer's ERP rollout as going well and said disruption would last at most another quarter. Instead, Dreams sales fell 34.7%, costing roughly $50 million of sales and $25 million of EBITDA. International operating margin collapsed 870 basis points to 9.4%.
• **Mattress Firm:** Same-store sales slid about 2%, versus flat in Q1 and slightly positive in Q2, with management acknowledging self-inflicted online weakness.
• **Freight costs:** Roughly $15 million of transportation and petroleum inflation erased an expected second-half price-cost benefit. Management signaled another price increase is likely in the first half of 2027.
• **Industry outlook:** Management now expects the industry to decline mid-single digits in the second half. That view has steadily worsened from "flat to slightly up" a year ago.
• **Segment outlooks:** North America and International like-for-like outlooks were cut to flattish, and Mattress Firm's to down low-single digits.

Earnings Whispers characterizes the guidance as narrowed, but it is more accurately a cut. The adjusted EPS range of $2.85 to $2.95 keeps the old low end while removing the top of the prior $2.85 to $3.15 range. That moves the midpoint to $2.90, down from $3.00 last quarter and $3.20 at the start of the year. Raised sales and EBITDA targets reflect Leggett consolidation, not organic improvement.

The call preserved a credible self-help story for 2027, and bulls will lean on it. Management framed a $3.40 EPS run-rate built from three pieces:

• the $2.90 midpoint;
• about $0.25 of Leggett wraparound accretion;
• about $0.25 from roughly $125 million of incremental synergies.

Management said that path requires no industry recovery, and estimated each point of industry growth adds about $0.10. Other planned catalysts include a Stearns & Foster launch that has taken about 6% incremental floor slots from competitors, a next-generation Tempur-Pedic Breeze launch in March 2027, and Mattress Firm store expansion toward 2,500-plus locations.

Bears have legitimate ammunition, however. Management's forecasts have repeatedly proven too optimistic, and Leggett adds exposure to soft residential and automotive end markets. The 2028 target of $5.15 now implies roughly 23% annual growth on a weaker revenue base, and management signaled it may be lowered.

Cash generation was a genuine positive. Operating cash flow reached $349 million, and free cash flow was about $290 million versus $182 million in Q2. Reported leverage fell to 2.69 times from 3.28 times a year earlier. Investors should note that the covenant calculation includes $330.5 million of pre-acquisition Leggett EBITDA and $145 million of synergies not yet realized.

Investor sentiment improved ahead of the report, rising from roughly neutral at 0.03 to a modestly positive 0.21. The stock has not followed that improvement. Shares entered the report at $64.17, down 1.7% from the open after the August release. That leaves them 12.2% below the 200-day moving average of $73.10.

The stock briefly reached $70.94 in early September, shortly after the Leggett closing, then fell to a 52-week low of $60.08 on October 1. It now sits only 6.8% above that low. Momentum and AVWAP trend readings remain negative, although the sequential growth reading is positive, reflecting the acquisition-driven step-up in reported scale. Modestly firmer sentiment heading into a report that delivered a two-sided miss and another guidance reduction makes the setup more fragile than the record headline implies.

The bottom line is that Somnigroup is assembling a larger, more vertically integrated bedding platform while its existing businesses lose volume and its forecasts keep slipping. The 2027 bridge, synergy pipeline and strong cash flow give the story a credible path. Credibility, however, is the scarce asset after three straight guidance cuts and a Dreams disruption that management underestimated. Until legacy sales stabilize and the company meets a forecast cleanly, the record adjusted numbers will be read more as acquisition math than as a turn in the underlying business.